22 December 2016

Putting Patients at the Center of the Perioperative Period

Dr. Adam Blomberg, Sheridan’s National Education Director, Anesthesiology Division, is a strong proponent of putting patients at the center of the entire perioperative period rather than just during preoperative testing. That’s the focus of a new program, TEMPO, that Sheridan has just begun to roll out formally at two partner facilities. 

TEMPO evolved from Sheridan’s proprietary ClearPATh preadmission testing (PAT) framework, which significantly streamlined the PAT process by increasing efficiency and freeing up other operating room (OR) resources. This framework has helped Sheridan anesthesiologists reduce or eliminate unnecessary testing, consultations and preoperative visits and given them the tools to coordinate all the aspects of patient care they touch. ClearPATh has made PAT patient-centric rather than a cookie cutter testing approach. It has also shortened wait times and reduced same-day cancellations – a win-win-win for hospitals, physicians and patients. 

The new TEMPO framework, which builds on the success of ClearPATh, gives anesthesiologists the tools to take ownership of the entire perioperative period, rather than just preoperative testing. Dr. Blomberg explained that TEMPO is named for the “coordinated rhythmic movement” that the new framework is designed to orchestrate to further increase efficiency, reduce delays and improve patient satisfaction throughout the perioperative period. Speaking with Megan Wood of Becker’s Spine Review, Dr. Blomberg said, "It's a coordinated effort when a patient goes to surgery and there should be a rhythm to it; it should not be sporadic."

For example, postoperative nausea is a common patient complaint. The TEMPO framework gives Sheridan anesthesiologists streamlined, readily accessible guidelines for postop nausea management as well as other aspects of postoperative pain management, including ERAS (enhanced recovery after surgery) programs. Sheridan is also preparing to pilot preoperative pharmacogenetic testing next year that will help anesthesiologists tailor medications based on patients’ genetic data. This will not only minimize negative drug reactions but also help identify patients with a predisposition to narcotic addiction. For these patients, Sheridan anesthesiologists can find pathways for treatment using no or limited opioids during the perioperative period.

"If you have standardized care with evidence-based medicine practices, you're going to improve outcomes," Dr. Blomberg explained.
 
To learn more about how Sheridan is using TEMPO to put patients at the center of perioperative care, read excerpts of Dr. Blomberg’s interview in Becker’s Spine Review article, “Centering the perioperative period around the patient.”